跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Amidrex Od-2 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Amidrex Od-2
Approved
STANDARD
Amidrex Od-2
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
69efa21760c2baa6
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
69efa21760c2baa6
Drug Approval Philippines Name
Amidrex Od-2
Product Name
Amidrex Od-2
Registration Number
DRP-12207
Brand Name
Amidrex Od-2
Generic Name
Risperidone
Dosage Form
Orally Disintegrating Tablet
Dosage Strength
2 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
29 June 2022
Expiry Date
29 June 2027
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
69efa21760c2baa6
Type
Standard
Back to Philippines FDA Approvals